InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 215768

Sunday, 04/19/2015 3:14:23 AM

Sunday, April 19, 2015 3:14:23 AM

Post# of 346385
Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL

Dmitry has been quite busy since joining Peregrine Pharmaceuticals as a KOL:

----------

Cancer Immunotherapy and Immunomonitoring Conference
Confirmed speakers
April 27-30, 2015, Ljubljana, Slovenia

Dmitry Gabrilovich
USA
The Wistar Institute

http://www.canceritim.org/faculty.html


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News